These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2496903)
1. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males. Molloi S; Mazess R; Bendsen H; Wilson M Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903 [TBL] [Abstract][Full Text] [Related]
2. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135 [TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298 [TBL] [Abstract][Full Text] [Related]
4. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP. Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217 [TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299 [TBL] [Abstract][Full Text] [Related]
6. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication. Smith ML; Martin W; Fogelman I; Bessent RG J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571 [TBL] [Abstract][Full Text] [Related]
7. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases. Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671 [TBL] [Abstract][Full Text] [Related]
8. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism. Hyldstrup L; McNair P; Ring P; Henriksen O Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC. Holland ME; Bugaj J; Heineman WR; Deutsch E Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091 [TBL] [Abstract][Full Text] [Related]
10. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate. Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414 [TBL] [Abstract][Full Text] [Related]
11. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate. Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703 [TBL] [Abstract][Full Text] [Related]
12. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera. Martin W; Fogelman I; Bessent RG J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399 [TBL] [Abstract][Full Text] [Related]
13. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)]. Seto H; Kakishita M; Futatsuya R Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840 [TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication. Rudd TG; Allen DR; Smith FD J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422 [TBL] [Abstract][Full Text] [Related]
15. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance. Blake GM; Moore AE; Fogelman I Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217 [TBL] [Abstract][Full Text] [Related]
16. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825 [TBL] [Abstract][Full Text] [Related]
17. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism. Hyldstrup L; Mogensen N; Jensen GF; McNair P; Transbøl I Scand J Clin Lab Invest; 1984 Apr; 44(2):105-9. PubMed ID: 6426035 [TBL] [Abstract][Full Text] [Related]
18. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator]. Anger K; Köhnen H; Stockberg H; Traut A; Winandi R Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885 [TBL] [Abstract][Full Text] [Related]
19. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies]. Kapitola J; Jahoda I; Kobos L; Vilimovská D Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622 [No Abstract] [Full Text] [Related]
20. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]